Nanochon
PrivateLast Round
Seed
Jan 12, 2026
Est. Valuation
$4M
Total Funding Raised
$10.33M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nanochon operates in Healthcare & Life Sciences and is based in Washington D.C.. Its latest recorded funding round was a Seed round in January 2026.
Nanochon is a medical device company developing 3D-printed, synthetic implants designed to repair cartilage and encourage new tissue growth for patients with joint injuries.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, 3D Printing, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanochon Comparables
Compare Nanochon with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Regentis Biomaterials Ltd. | 84% | |
| Sparta Biomedical | 83% | |
| Askel Healthcare | 83% |
For institutional investors. Book with your work email.
Nanochon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 12, 2026 | ||||
| Grant | Oct 2, 2025 | ||||
| Seed | May 6, 2024 | ||||
| Seed | Oct 21, 2021 | ||||
| Grant | Jul 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nanochon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Virginia LVG Seed Fund | Seed |
| Wealthing VC Fund | Seed |
| TEDCO | Seed |
| Wealthing VC Club | Seed |
| Maryland Stem Cell Research Fund | Grant |
| Ecphora Capital | Seed |
| Alumni Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 152% MoM.
- Jan 12, 2026
$4M round led by Cultivate(MD) and Ecphora Capital.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 8, 2026
Nanochon, Inc. is developing Chondrograft, a 3D-printed implant for focal cartilage lesions of the knee, and studies it in a first-in-human early feasibility trial at The Panama Clinic in Panama.
- receives_awardSep 2, 2026
Nanochon, Inc. receives Breakthrough Device Designation from the U.S. Food and Drug Administration.
- is_developingAug 17, 2026
Nanochon, Inc. develops Chondrograft(TM), a patented implant for treating knee articular cartilage defects, and receives Panama Ministry of Health approval on Aug 14th '26 to initiate a first-in-human study at The Panama Clinic in Panama, led by Drs. Juan Osorio and Emilio Tufiño.
For institutional investors. Book with your work email.
Nanochon Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nanochon's valuation, stock price, and market status.
Is Nanochon a public or private company?
Nanochon is a private company.
What is the current stock price of Nanochon?
Nanochon is a private company, so its shares have no public market price. Caplight tracks Nanochon's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanochon worth (valuation)?
Nanochon's valuation is estimated at $4.0M based on funding round data.
Can I buy Nanochon stock?
Nanochon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanochon's last funding round?
Nanochon's most recent funding round was Seed on January 12, 2026.
Who are the main investors in Nanochon?
Key investors in Nanochon include University of Virginia LVG Seed Fund, Ecphora Capital, cultivate(MD).
Will Nanochon IPO soon?
No public IPO plans have been announced for Nanochon.
How can I track Nanochon secondary market activity?
Caplight tracks bids, offers, and trades in Nanochon's shares on secondary markets.